s6y
Company name or ticker
Search
AEON Biopharma, Inc.
3
Bencich John: Initial statement of beneficial ownership of securities
Filed
Friday, April 3, 2026
Period
Apr 1, 2026
Accession number
0001104659-26-039696
Documents
OWNERSHIP DOCUMENT
3
EXHIBIT 24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header